GalNAc derivatives
US-12503698-B2 · Dec 23, 2025 · US
This page is not indexed by search engines while we improve data quality.
Janssen Biopharma Inc patents
Janssen Biopharma Inc holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 2 |
| First publication | Aug 6, 2019 |
| Latest publication | Dec 23, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Modified oligonucleotides and methods of use
US-12077757-B2 · Sep 3, 2024 · US
Substituted nucleosides, nucleotides and analogs thereof
US-10370401-B2 · Aug 6, 2019 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
GalNAc derivatives
US-12503698-B2 · Dec 23, 2025 · US
Modified oligonucleotides and methods of use
US-12077757-B2 · Sep 3, 2024 · US
Substituted nucleosides, nucleotides and analogs thereof
US-10370401-B2 · Aug 6, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 3 |
| Cross-Sectional Technologies | 1 |